Calorie-burning 'good' fat can be protected, says study

August 25, 2016

UC San Francisco researchers studying beige fat -- a calorie-burning tissue that can help to ward off obesity and diabetes -- have discovered a new strategy to cultivate this beneficial blubber.

Beige fat cells have the ability to switch back and forth between an energy-hoarding "white" state and an energy-burning "brown" state, the new research found, based on how they handle the cellular power plants known as mitochondria: Preventing beige fat cells from digesting their own mitochondria traps them in the energy-burning state. In mice, this intervention successfully protected against obesity and pre-diabetic symptoms, raising hopes for future applications in human patients.

The results - which appear Aug. 25, 2016 in the journal Cell Metabolism -- represent a key new advance in efforts to use beige fat to battle the growing worldwide epidemics of obesity and type 2 diabetes, according to senior investigator Shingo Kajimura, PhD, an associate professor of cell and tissue biology in UCSF's School of Dentistry.

Research may aid efforts to enhance and maintain energy-burning fat in humans

All mammals, including humans, have two types of fat with completely opposite functions: white, which stores energy and is linked with diabetes and obesity; and brown, which produces heat by burning energy and is associated with leanness.

Human babies are born with brown fat as a natural defense against cold, but it wasn't until 2009 that researchers first discovered that adult humans have energy-burning fat as well. In 2015, Kajimura's group demonstrated that most of this healthy fat in humans is not so-called classical brown fat of the type that babies are born with, but a completely different type of cell, which the researchers dubbed "beige fat." Beige fat is found within white fat and has the ability to quickly convert from an energy-storing state to an energy-burning state in response to environmental changes, such as cold or other stressors.

Many obesity researchers hope to harness the energy-burning capacity of beige and brown fat to help patients lose weight: just two ounces of the stuff can burn up to 200 calories a day when the temperature drops. But just exposing patients to cold temperatures -- or giving them drugs that trick the body into thinking it's cold -- have proven ineffective in early trials because most people who are obese lack a significant amount of active brown fat. These approaches also have dangerous cardiovascular side effects, which are of particular concern in obese patients.

Kajimura's group recently identified new pharmacological strategies for transforming white fat into beige fat in mice, which showed significant health benefits without cardiovascular side effects. However, the researchers soon realized that when these drug treatments are stopped, the new beige fat just reverts to white fat again within weeks.

"For many years our focus has been on learning to convert white fat into beige fat," said Kajimura, who holds joint appointments in UCSF's Diabetes Center and at the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research. "Now we're realizing we also have to think about how to keep it there for longer time."

Mitochondria play a key role in setting fat cells' function

In their new paper, a team led by Kajimura's graduate student Svetlana Altshuler-Keylin demonstrated that when they revert to white fat, beige fat cells digest their mitochondria -- a structure found inside cells that burns glucose and turns it into energy. When the research team deleted key genes to prevent beige fat cells from eating their own mitochondria in mice, they succeeded in preserving the beige fat and its health benefits.

First, the team needed to show that individual beige fat cells directly convert back to white fat - that they weren't dying and being replaced by new white fat cells, for instance. To demonstrate this, Altshuler-Keylin embedded cells in a gel and used a microscope to track their transformation for 10 days. She saw that beige fat cells quickly lost their characteristic marbled appearance, developing the single large droplet of oily lipid typical of white fat cells. [See Video]

"So we knew beige fat tends to disappear, but we wanted to know why," Altshuler-Keylin said. "We knew that the color of brown and beige fat comes from the amount of pigmented mitochondria they contain, so we wondered whether something was going on with the mitochondria when beige fat turns white."

The researchers analyzed changes in gene expression during the beige-to-white transition. They found that, indeed, a cluster of genes related to mitochondria was highly active in beige fat, but declined sharply as beige fat turned white. Using fluorescent proteins to visualize mitochondria, the researchers confirmed that these cellular power plants increase in number during "beiging", but decline during "whitening."

Further gene expression analysis suggested that autophagy -- a common process in which cells digest their own internal components when they are defective or unneeded -- actively culls mitochondria during the beige-to-white transition. Altshuler-Keylin suspected that controlling autophagy might be the key to keeping beige cells burning energy. She obtained some mice with key autophagy genes deleted in beige fat cells, boosted beige fat levels in these mice with cold or drugs, then withdrew these stimulating factors. She found that the mice with the autophagy genes knocked out retained much more beige fat, presumably because they were unable to revert it back to white fat.

"That was the first time in my career I've seen such a striking result," Altshuler-Keylin said, "I had to run around the lab and show it to everybody."

Further tests showed that mice with autophagy blocked in their fat cells not only retained beige fat longer than normal mice, but also burned energy more quickly - without any obvious differences in activity levels or appetite. Placed on a high-fat diet for 8 weeks, these mice also gained considerably less weight and retained healthier glucose metabolism and insulin sensitivity, which are signs of protection against type 2 diabetes.

Kajimura hopes the new finding will contribute to efforts to boost beige fat in people with obesity, particularly older adults. "With age you tend to naturally lose your beige fat, which we think is one of the main drivers of age-related obesity. Your calorie intake stays the same, but you're not burning as much," he said. "Maybe by understanding this process we can help people keep more beige fat, and therefore stay healthier."
Additional authors on the paper were Kosaku Shinoda, PhD, Yutaka Hasegawa, MD,. PhD, Kenji Ikeda, MD, PhD, Haemin Hong, Qianqian Kang, and Yangyu Yang, of the UCSF Department of Cell and Tissue Biology, UCSF Diabetes Center, and Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research; Rushika Perera, PhD, of the UCSF departments of Anatomy and Pathology; and Jayanta Debnath, MD, of the Department of Pathology. Perera and Debnath are both members of the Hellen Diller Comprehensive Cancer Center at UCSF.

Support for the research includes grants from the National Institutes of Health (DK97441, DK108822, and CA126792); the Diabetes and Endocrinology Research Center at UCSF (DK63720), funded by the National Institute of Diabetes and Digestive and Kidney Diseases; the Pew Charitable Trust; the Japan Science and Technology Agency; the American Cancer Society; the Pancreatic Cancer Action Network; the American Heart Association (15PRE23050029); the California Institute for Regenerative Medicine (TG2-01153); the Larry L. Hillblom Foundation (2014-D-025-FEL); the Manpei Suziki Diabetes Foundation; and the CSC Charitable Foundation (201506350063). The authors declare no conflicting financial interests.

About UCSF: UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences; and a preeminent biomedical research enterprise. It also includes UCSF Health, which comprises two top-ranked hospitals, UCSF Medical Center and UCSF Benioff Children's Hospital San Francisco, and other partner and affiliated hospitals and healthcare providers throughout the Bay Area. Please visit

Follow UCSF | | |


University of California - San Francisco

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to